ArticleMolecular and clinical oncology2018

Paradoxical response to osimertinib therapy in a patient with T790M-mutated lung adenocarcinoma.

Shinichiro Okauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.